ACS Combinatorial Science
Letter
REFERENCES
■
(1) (a) Mmutlane, E. M.; Harris, J. M.; Padwa, A. 1,3-Dipolar
Cycloaddition Chemistry for the Preparation of Novel Indolizinone-
Based Compounds. J. Org. Chem. 2005, 70 (20), 8055−8063.
(b) Harris, J. M.; Padwa, A. A New β-Carbolinone Synthesis Using
a Rh(II)-Promoted [3 + 2]-Cycloaddition and Pd(0) Cross-Coupling/
Heck Cyclization Chemistry. Org. Lett. 2003, 5 (22), 4195−4197.
(c) Padwa, A.; Sheehan, S. M.; Straub, C. S. An Isomuenchnone-Based
Method for the Synthesis of Highly Substituted 2(1H)-Pyridones. J.
Org. Chem. 1999, 64 (23), 8648−8659. (d) Straub, C. S.; Padwa, A.
Synthesis of the Angiotensin Converting Enzyme Inhibitor
(−)-A58365A via an Isomunchnone Cycloaddition Reaction. Org.
Lett. 1999, 1 (1), 83−85. (e) Sheehan, S. M.; Padwa, A. New Synthetic
Route to 2-Pyridones and Its Application toward the Synthesis of
(+)-Ipalbidine. J. Org. Chem. 1997, 62 (3), 438−439.
(2) (a) Tang, C.-J.; Babjak, M.; Anderson, R. J.; Greene, A. E.;
Kanazawa, A. Novel, efficient total synthesis of natural 20(S)-
camptothecin. Org. Biomol. Chem. 2006, 4 (20), 3757−3759.
(b) Babjak, M.; Kanazawa, A.; Anderson, R. J.; Greene, A. E. Concise
Synthesis of 22-Hydroxyacuminatine, Cytotoxic Camptothecinoid
from Camptotheca acuminata, by Pyridone Benzannulation. Org.
Biomol. Chem. 2006, 4 (3), 407−409. (c) Anderson, R. J.; Raolji, G.
B.; Kanazawa, A.; Greene, A. E.; Novel, A. Expeditious Synthesis of
Racemic Camptothecin. Org. Lett. 2005, 7 (14), 2989−2991.
(d) Raolji, G. B.; Garcon, S.; Greene, A. E.; Kanazawa, A. A Modular
Approach to Oxoindolizino Quinolines: Efficient Synthesis of
Mappicine Ketone (Nothapodytine B). Angew. Chem., Int. Ed. 2003,
42 (41), 5059−5061.
(3) Teshima, Y.; Shin-ya, K.; Shimazu, A.; Furihata, K.; Chul, H. S.;
Hayakawa, Y.; Nagai, K.; Seto, H. Isolation and Structural Elucidation
of Pyridoxatin, A Free Radical Scavenger of Microbial Origin. J.
Antibiot. 1991, 44 (6), 685−7.
(4) Bai, D. L.; Tang, X. C.; He, X. C.; Huperzine, A. A Potential
Therapeutic Agent for Treatment of Alzheimer’s Disease. Curr. Med.
Chem. 2000, 7 (3), 355−374.
(5) (a) Hunt, A. H.; Mynderse, J. S.; Samlaska, S. K.; Fukuda, D. S.;
Maciak, G. M.; Kirst, H. A.; Occolowitz, J. L.; Swartzendruber, J. K.;
Jones, N. D. Structure Elucidation of A58365A and A58365B,
Angiotensin Converting Enzyme Inhibitors Produced by Streptomyces
chromofuscus. J. Antibiot. 1988, 41 (6), 771−779. (b) Mynderse, J. S.;
Samlaska, S. K.; Fukuda, D. S.; Du Bus, R. H.; Baker, P. J. Isolation of
A58365A and A58365B, Angiotensin Converting Enzyme Inhibitors
Produced by Streptomyces chromofuscus. J. Antibiot. 1985, 38 (8),
1003−1007.
(6) (a) Collins, I. J.; Leeson, P. D.; Moyes, C. R.; Rowley, M.;
Fletcher, S. R.; Harrison, T.; Teall, M. R.; Nadin, A.; Sparey, T. J.
Preparation of Heteroarylpyridones as GABAA Alpha 2/Alpha 3
Ligands, 98-GB1593 9855480, 19980601, 1998; (b) Harrison, T.;
Moyes, C. R.; Nadin, A.; Owens, A. P.; Lewis, R. T. Preparation of
Tricyclic Pyridone Analogs As GABA-A Receptor Ligands, 98-GB1167
9850384, 19980422, 1998; (c) Collins, I.; Castro, J. L. A Convenient
Synthesis of Highly Substituted 2-Pyridones. Tetrahedron Lett. 1999,
40, 4069−4072.
(7) Brunner, H.; Furst, J.; Ziegler, J. Enantioselektive katalyse:
LXXXI. Optisch aktive zweischalenphosphine. J. Organomet. Chem.
1993, 454 (1−2), 87−94.
(8) Tan, D. S. Diversity-Oriented Synthesis: Exploring the
Intersections between Chemistry and Biology. Nat. Chem. Biol.
2005, 1 (2), 74−84.
(9) MOE, version 2010.10; Chemical Computing Group: Quebec,
Canada, 2010.
(10) Khalaf, J.; Estrella-Jimenez, M. E.; Shashack, M. J.; Phatak, S. S.;
Zhang, S.; Gilbertson, S. R. Design, Synthesis, and Diversification of
3,5-Substituted Enone Library. ACS Comb. Sci. 2011, 13 (4), 351−356.
D
dx.doi.org/10.1021/co400067q | ACS Comb. Sci. XXXX, XXX, XXX−XXX